External defibrillators market analysis report by Future Market Insights shows that global sales in 2021 were held at USD 3 Billion. With 10.4%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth.
The growing incidence of cardiac disorders such as arrhythmias and bradycardias, among others, the rise in the geriatric population, integration of advanced technology, growing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders contribute to an increase in the use of external defibrillators, consequently driving the market. Manual External Defibrillators are expected to be the highest revenue-generating application, with a CAGR of around 11.4% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global External Defibrillators Market (2022) | USD 3.3 Billion |
| Global External Defibrillators Market (2032) | USD 8.8 Billion |
| Global External Defibrillators Market CAGR (2022 to 2032) | 10.4% |
| North America External Defibrillators Market | 11.2% |
| USA External Defibrillators Market (2022) | USD 1.2 Billion |
| Key Companies Profiled | Medtronic; Stryker Corporation; Koninklijke Philips N.V.; Asahi Kasei Corporation; Boston Scientific Corporation; Abbott; Nihon Kohden; MicroPort; BIOTRONIK; CU Medical Systems; METsis Medikal; Mediana Co. Ltd.; Mindray Medical International |
As per the External Defibrillator research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of external defibrillators increased at around 8.6% CAGR, wherein, countries such as the USA, China, and Japan held a significant share in the global market.
The constant surge in urbanization has also aggravated healthcare needs across several countries. Owing to this, the demand for an external defibrillator is projected to grow at a CAGR of 10.4% over the coming 10 years.
In the elderly population and individuals suffering from chronic conditions such as high blood pressure, obesity, and heart disorders, atrial fibrillation, which is characterized by an irregular and most often rapid heart rate, can raise the risk of stroke, heart failure, and other heart-related complications. According to a study released in NCBI 2021, atrial fibrillation is perhaps the most common cardiac arrhythmia, with a global prevalence of 37.5 billion people diagnosed in 2017. Furthermore, according to the WHO report for 2021, heart disease and stroke account for 85% of all cardiovascular fatalities.
Defibrillators are devices that provide an electric shock to restore a regular heartbeat. They are used to treat or prevent arrhythmias. Furthermore, the launch of numerous new defibrillators with easier insertion technology, smaller size, and fewer or no leads placed in the heart is expected to propel the external defibrillators market growth. Biotronik, for example, introduced the Acticor gadget series of innovative ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds) in 2019. The hybrid ICD Acticor devices provide dual-chamber diagnostics without the use of an atrial lead.
The rising prevalence of hypertension among the global population, as well as an increase in cardiovascular illnesses such as arrhythmias and bradycardias, will boost the external defibrillators market. In addition to an aging population, people who are more likely to have heart-related disorders are expected to boost the external defibrillators market.
Furthermore, rising healthcare expenditures, improved healthcare infrastructure, technical improvements, and an increase in disposable income in developing nations are all factors that are expected to enhance the market. Furthermore, the increasing push of several governments to install external defibrillators in public locations other than hospitals in order to prevent sudden cardiac death is a major driver driving the growth of the external defibrillators market.
Rapid technical advancements, as well as favorable government regulation, are expected to propel the External Defibrillators market over the forecast period.
AEDs (automated external defibrillators) are life-saving devices that assist in cardiac rhythm correction. The rising prevalence of cardiac disorders, the expanding elderly population, and technical developments in the industry, supported by increased investment by market participants, are the key factors propelling the market.
During the projected period, North America is expected to dominate the external defibrillators market. In 2021, North America had the highest revenue share, accounting for more than 35%. This dominance can be attributed to the rising prevalence of cardiovascular disorders, improved healthcare infrastructure, and the presence of significant external defibrillator market participants in the region. Furthermore, the risks of developing cardiovascular disease are skyrocketing in the United States. The presence of key manufacturers in the region, such as Stryker, ZOLL, and Phillips, among others, would also boost the market for external defibrillators.
In 2021, Boston Scientific, for example, reported that it had distributed around 33,000 CRT-Ds devices worldwide, including Ring true, Autogen, Dynagen, Incepta, and Cognis. There were 16,500 registered devices in the United States alone, indicating a significant adoption rate.
The market for external defibrillator treatments in North America is also rising due to the region's growing geriatric population and high consumer awareness. Furthermore, the presence of market competitors and increasing demands for modern medical systems in the area contribute to the region's leading market position.
Due to improvements in research infrastructure, an increase in the geriatric population, and a high prevalence of cardiovascular illnesses, the European market is projected to swell. Furthermore, Asia Pacific held a significant share and is expected to be the fastest-growing regional market, owing to an increased incidence of heart attacks, and the presence of a large patient pool suffering from cardiovascular diseases; especially in emerging economies such as Hong Kong and Singapore.
The improvement of technology in these countries has created a profitable opportunity for the worldwide defibrillator market to flourish. During the projection period, the market in Latin America and the Middle East, and Africa is expected to rise at a slower pace.
With an over 11.5% projected growth rate, external defibrillators market revenue is expected to grow at the fastest pace in the USA, from 2022 to 2032. The market in the USA is predicted to grow due to the presence of a well-developed healthcare infrastructure, which is also rising due to the region's growing geriatric population and high consumer awareness. Furthermore, the presence of established market competitors and increasing demand for modern medical systems in the area contribute to the region's leading market position.
The external defibrillators market in the United Kingdom is expected to reach a valuation of 326 Million by 2032, at a CAGR of 10%. The market growth from 2017 to 2021 was observed at 8.5%.
The Japanese external defibrillator market is expected to witness an absolute dollar growth of USD 260 Million, growing at a CAGR of 10.3% from 2022 to 2032. The market is projected to reach a valuation of USD 416.5 Million by 2032.
The external defibrillators market in South Korea is projected to account for an absolute dollar opportunity of USD 99 Million. By 2032, it will reach a valuation of USD 156.5 Million growing at a CAGR of 10.5%.
During the projection period, manual external defibrillators are anticipated to lead the market. The rising frequency of cardiovascular disorders and the introduction of technologically improved defibrillators are responsible for the considerable share of manual external defibrillators. Besides, manual external defibrillators are also cost-effective, which is the key factor for their high share.
Some of the key companies operating in the external defibrillators market include Medtronic, Stryker Corporation, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, Nihon Kohden, MicroPort, BIOTRONIK, CU Medical Systems, METsis Medikal, Mediana Co. Ltd., and Mindray Medical International.
Some of the recent developments by key external defibrillator providers are as follows:
Similarly, the Future Market Insights team has been keeping track of recent advancements in the field of external defibrillators, which are detailed in the complete research.
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Latin America Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 11: Europe Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 12: Europe Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 15: Asia Pacific Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Table 16: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: MEA Market Value (US$ Million) Forecast by Product, 2017 to 2032
Table 18: MEA Market Value (US$ Million) Forecast by End-use, 2017 to 2032
Figure 1: Global Market Value (US$ Million) by Product, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by End-use, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 7: Global Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 10: Global Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 13: Global Market Attractiveness by Product, 2022 to 2032
Figure 14: Global Market Attractiveness by End-use, 2022 to 2032
Figure 15: Global Market Attractiveness by Region, 2022 to 2032
Figure 16: North America Market Value (US$ Million) by Product, 2022 to 2032
Figure 17: North America Market Value (US$ Million) by End-use, 2022 to 2032
Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 22: North America Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 28: North America Market Attractiveness by Product, 2022 to 2032
Figure 29: North America Market Attractiveness by End-use, 2022 to 2032
Figure 30: North America Market Attractiveness by Country, 2022 to 2032
Figure 31: Latin America Market Value (US$ Million) by Product, 2022 to 2032
Figure 32: Latin America Market Value (US$ Million) by End-use, 2022 to 2032
Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 40: Latin America Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 43: Latin America Market Attractiveness by Product, 2022 to 2032
Figure 44: Latin America Market Attractiveness by End-use, 2022 to 2032
Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 46: Europe Market Value (US$ Million) by Product, 2022 to 2032
Figure 47: Europe Market Value (US$ Million) by End-use, 2022 to 2032
Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 52: Europe Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 55: Europe Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 58: Europe Market Attractiveness by Product, 2022 to 2032
Figure 59: Europe Market Attractiveness by End-use, 2022 to 2032
Figure 60: Europe Market Attractiveness by Country, 2022 to 2032
Figure 61: Asia Pacific Market Value (US$ Million) by Product, 2022 to 2032
Figure 62: Asia Pacific Market Value (US$ Million) by End-use, 2022 to 2032
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 73: Asia Pacific Market Attractiveness by Product, 2022 to 2032
Figure 74: Asia Pacific Market Attractiveness by End-use, 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 76: MEA Market Value (US$ Million) by Product, 2022 to 2032
Figure 77: MEA Market Value (US$ Million) by End-use, 2022 to 2032
Figure 78: MEA Market Value (US$ Million) by Country, 2022 to 2032
Figure 79: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 82: MEA Market Value (US$ Million) Analysis by Product, 2017 to 2032
Figure 83: MEA Market Value Share (%) and BPS Analysis by Product, 2022 to 2032
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Product, 2022 to 2032
Figure 85: MEA Market Value (US$ Million) Analysis by End-use, 2017 to 2032
Figure 86: MEA Market Value Share (%) and BPS Analysis by End-use, 2022 to 2032
Figure 87: MEA Market Y-o-Y Growth (%) Projections by End-use, 2022 to 2032
Figure 88: MEA Market Attractiveness by Product, 2022 to 2032
Figure 89: MEA Market Attractiveness by End-use, 2022 to 2032
Figure 90: MEA Market Attractiveness by Country, 2022 to 2032
The External defibrillators market is worth more than USD 3 Billion at present.
The value of external defibrillators is projected to increase at a CAGR of around 10.4% from 2022 to 2032.
The value of External Defibrillators increased at a CAGR of around 8.6% from 2017 to 2021.
Factors responsible for the growth of the External defibrillators market include the growing demand for health solutions.
The top 5 countries driving the demand for external defibrillators are the USA, United Kingdom, China, Japan, and South Korea
The market in North America is expected to grow at the highest CAGR of around 11.2%.
External Defibrillators Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
